Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status

American Journal of Gastroenterology

Volumn 103, Issue 1, 2008, Pages 62-70

  Nakamura, Tsuneya ^a   Seto, Masao ^a   Tajika, Masahiro ^a   Kawai, Hiroki ^a   Yokoi, Takio ^a   Yatabe, Yasushi ^a   Nakamura, Shigeo ^b  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLADRIBINE; CLARITHROMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; METRONIDAZOLE; OMEPRAZOLE; PREDNISOLONE; PROTON PUMP INHIBITOR; RITUXIMAB; VINCRISTINE SULFATE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CLINICAL FEATURE; DISEASE COURSE; ENDOSCOPY; ERADICATION THERAPY; FEMALE; HELICOBACTER PYLORI; HUMAN; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; STOMACH CARCINOMA; TOTAL STOMACH RESECTION;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BIOPSY; COMBINED MODALITY THERAPY; DNA, NEOPLASM; ENDOSCOPY, GASTROINTESTINAL; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; PROGNOSIS; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 37849034151     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01521.x     Document Type: Article

References (32)

1. Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993 342 : 575 7.
2. Morgner A, Bayerdorffer E, Neubauer A, et al. Gastric MALT lymphoma and its relationship to Helicobacter pylori infection: Management and pathogenesis of the disease. Microsc Res Tech 2000 48 : 349 56.
3. Neubauer A, Thiede C, Morgner A, et al. Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. J Natl Cancer Inst 1997 89 : 1350 5.
4. Akagi T, Motegi M, Tamura A, et al. A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. Oncogene 1999 18 : 5785 94.
5. Dierlamm J, Baens M, Wlodarska I, et al. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 1999 93 : 3601 9.
6. Nakamura T, Nakamura S, Yonezumi M, et al. Helicobacter pylori and the t(11;18)(q21;q21) translocation in gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type. Jpn J Cancer Res 2000 91 : 301 9.
7. Sugiyama T, Asaka M, Nakamura T, et al. API2-MALT1 chimeric transcript is a predictive marker for the responsiveness of H. pylori eradication treatment in low-grade gastric MALT lymphoma. Gastroenterology 2001 120 : 1884 5.
8. Nakamura T, Nakamura S, Yokoi T, et al. Clinicopathologic comparison between the API2-MALT1 chimeric transcript- positive and -negative gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type. Jpn J Cancer Res 2002 93 : 677 84.
9. Inagaki H, Nakamura T, Li C, et al. Gastric MALT lymphomas are divided into three groups based on responsiveness to Helicobacter pylori eradication and detection of API2-MALT1 fusion. Am J Surg Pathol 2004 28 : 1560 7.
10. Ye H, Liu H, Raderer M, et al. High incidence of t(11;18)(q21;q21) in Helicobacter pylori-negative gastric MALT lymphoma. Blood 2003 101 : 2547 50.
11. Ott G, Katzenberger T, Greiner A, et al. The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type. Cancer Res 1997 57 : 3944 8.
12. Starostik P, Patzner J, Greiner A, et al. Gastric marginal zone B-cell lymphomas of MALT type develop along 2 distinct pathogenetic pathways. Blood 2002 99 : 3 9.
13. Streubel B, Ye H, Du MQ, et al. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma. Oncology 2004 66 : 476 80.
14. Isaacson P, Wright DH. Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue. Cancer 1984 53 : 2515 24.
15. Rohatiner A, d'Amore F, Coiffier B, et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 1994 5 : 397 400.
16. Motegi M, Yonezumi M, Suzuki H, et al. API2-MALT1 chimeric transcripts involved in mucosa-associated lymphoid tissue type lymphoma predict heterogeneous products. Am J Pathol 2000 156 : 807 12.
17. Inagaki H, Okabe M, Seto M, et al. API2-MALT1 fusion transcripts involved in mucosa-associated lymphoid tissue lymphoma: Multiplex RT-PCR detection using formalin-fixed paraffin-embedded specimens. Am J Pathol 2001 158 : 699 706.
18. Schechter NR, Portlock CS, Yahalom J. Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone. J Clin Oncol 1998 16 : 1916 21.
19. Isaka T, Nakamura T, Tajika M, et al. API2-MALT1 chimeric transcript-positive gastroduodenal MALT lymphoma with subsequent development of adenocarcinoma as a collision tumour over a clinical course of 7 years. Histopathology 2007 51 : 119 22.
20. Isaacson PG, Du MQ. MALT lymphoma: From morphology to molecules. Nat Rev Cancer 2004 4 : 644 53.
21. Savio A, Zamboni G, Capelli P, et al. Relapse of low-grade gastric MALT lymphoma after Helicobacter pylori eradication: True relapse or persistence? Long-term post-treatment follow-up of a multicenter trial in the north-east of Italy and evaluation of the diagnostic protocol's adequacy. Recent Results Cancer Res 2000 156 : 116 24.
22. Iwano M, Okazaki K, Uchida K, et al. Characteristics of gastric B-cell lymphoma of mucosa-associated lymphoid tissue type involving multiple organs. J Gastroenterol 2004 39 : 739 46.
23. Fischbach W, Goebeler-Kolve ME, Dragosics B, et al. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: Experience from a large prospective series. Gut 2004 53 : 34 7.
24. Isaacson PG, Diss TC, Wotherspoon AC, et al. Long-term follow-up of gastric MALT lymphoma treated by eradication of H. pylori with antibodies [letter]. Gastroenterology 1999 117 : 750 1.
25. Thiede C, Wundisch T, Alpen B, et al. Long-term persistence of monoclonal B cells after cure of Helicobacter pylori infection and complete histologic remission in gastric mucosa-associated lymphoid tissue B-cell lymphoma. J Clin Oncol 2001 19 : 1600 9.
26. Zhou Y, Ye H, Martin-Subero JI, et al. Distinct comparative genomic hybridisation profiles in gastric mucosa-associated lymphoid tissue lymphomas with and without t(11;18)(q21;q21). Br J Haematol 2006 133 : 35 42.
27. Fukuhara N, Nakamura T, Nakagawa M, et al. Chromosomal imbalances are associated with outcome of Helicobacter pylori eradication in t(11;18)(q21;q21) negative gastric mucosa-associated lymphoid tissue lymphomas. Genes Chromosomes Cancer 2007 46 : 784 90.
28. Liu H, Ye H, Ruskone-Fourmestraux A, et al. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 2002 122 : 1286 94.
29. Wundisch T, Thiede C, Morgner A, et al. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J Clin Oncol 2005 23 : 8018 24.
30. Sakugawa ST, Yoshino T, Nakamura S, et al. API2-MALT1 fusion gene in colorectal lymphoma. Mod Pathol 2003 16 : 1232 41.
31. Rosenwald A, Ott G, Stilgenbauer S, et al. Exclusive detection of the t(11;18)(q21;q21) in extranodal marginal zone B cell lymphomas (MZBL) of MALT type in contrast to other MZBL and extranodal large B cell lymphomas. Am J Pathol 1999 155 : 1817 21.
32. Copie-Bergman C, Locher C, Levy M, et al. Metachronous gastric MALT lymphoma and early gastric cancer: Is residual lymphoma a risk factor for the development of gastric carcinoma? Ann Oncol 2005 16 : 1232 6.